Godfree Roberts: Revolutionizing Healthcare: China’s 20 Top Cures of 2025
A promising new year for sufferers of Lupus, Cancer, Thalassemia, Alzheimers, Diabetes, Autoimmune Diseases, Lung Cancer, Asthma and more..
Godfree says: A subscriber asked if a cure existed for his Thai wife’s acute thalassemia, which is endemic there. I located the Chinese hospital that developed a cure and I’m delighted to report that not only is she well again, but the disfiguring signs of the condition are slowly disappearing.
If you know of someone suffering from a condition in this list, feel free to pass this un-paywalled issue along to them. Happy New Year!
https://herecomeschina.substack.com/
- China beats US in medical research.
- Dozens of lupus patients cured.
- 32 Paralysis Patients Control Grasping with their brains
- Acute thalassemia cured with transformer Base Editing (tBE).
- LVA surgery cures Alzheimer’s.
- Deep brain stimulator controls Meige syndrome.
- Bioengineered, donor-derived immune cells cure autoimmune diseases
- Highly potent HIV-1 antibody achieves 100% AIDS inhibition.The first IVF baby treated with whole genome amplification turned 10.
- CAR-T cell therapy cures 20 children with systemic lupus erythematosus.
- AI-based treatment fixes gastric cancer and prevents tumors.
- CRISPR-modified immune cells cure severe autoimmune conditions.
- World’s first stem cell diabetes reversal–in 90 days.
- Single shot cell therapy cures asthma.
- Embryonic pronucleus removal produces a healthy baby.
- FDA: China’s Sunvozertinib ‘breakthrough therapy’ for recalcitrant lung cancer.
- Implanted islet cells save end-stage Type 2 diabetic.
- One-shot cell therapy cures asthma.
- Patients’ own P63+ progenitor lung cells fix COPD-damaged lung tissue.
- Brain-Computer Interfaces restores completely paralyzed patients’ control.
- Pig Liver-human Xenotransplantation functions without rejection.
Maybe 19: Authorities ban use of LVA surgery to treat Alzheimer’s By WANG XIAOYU | China Daily Global | Updated: 2025-07-11 00:00
https://epaper.chinadaily.com.cn/a/202507/11/WS68705d17a31072f9198f3d8c.html